Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms
This review is based on the presentations and deliberations at the 7th John Goldman Chronic Myeloid Leukemia (CML) and Myeloproliferative Neoplasms (MPN) Colloquium which took place in Estoril, Portugal on the 15th October 2017, and the 11th post-ASH International Workshop on CML and MPN which took...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
14 February 2018
|
| In: |
Leukemia research
Year: 2018, Jahrgang: 67, Pages: 67-74 |
| ISSN: | 1873-5835 |
| DOI: | 10.1016/j.leukres.2018.02.008 |
| Online-Zugang: | Verlag, Pay-per-use, Volltext: https://doi.org/10.1016/j.leukres.2018.02.008 Verlag, Pay-per-use, Volltext: http://www.sciencedirect.com/science/article/pii/S0145212618300432 
|
| Verfasserangaben: | Tariq I. Mughal, Jason Gotlib, Ruben Mesa, Steffen Koschmieder, H. Jean Khoury, Jorge E. Cortes, Tiziano Barbui, Rüdiger Hehlmann, Michael Mauro, Susanne Saussele, Jerald P. Radich, Richard A. Van Etten, Giuseppe Saglio, Srdnan Verstovek, Robert Peter Gale, Omar Abdel-Wahab |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1666322628 | ||
| 003 | DE-627 | ||
| 005 | 20220816161525.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190527s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.leukres.2018.02.008 |2 doi | |
| 035 | |a (DE-627)1666322628 | ||
| 035 | |a (DE-599)KXP1666322628 | ||
| 035 | |a (OCoLC)1341225588 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Mughal, Tariq I. |e VerfasserIn |0 (DE-588)135827116 |0 (DE-627)571679277 |0 (DE-576)300667701 |4 aut | |
| 245 | 1 | 0 | |a Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms |c Tariq I. Mughal, Jason Gotlib, Ruben Mesa, Steffen Koschmieder, H. Jean Khoury, Jorge E. Cortes, Tiziano Barbui, Rüdiger Hehlmann, Michael Mauro, Susanne Saussele, Jerald P. Radich, Richard A. Van Etten, Giuseppe Saglio, Srdnan Verstovek, Robert Peter Gale, Omar Abdel-Wahab |
| 264 | 1 | |c 14 February 2018 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.05.2019 | ||
| 520 | |a This review is based on the presentations and deliberations at the 7th John Goldman Chronic Myeloid Leukemia (CML) and Myeloproliferative Neoplasms (MPN) Colloquium which took place in Estoril, Portugal on the 15th October 2017, and the 11th post-ASH International Workshop on CML and MPN which took place on the 6th-7th December 2016, immediately after the 58th American Society of Hematology Annual Meeting. Rather than present a resume of the proceedings, we have elected to address some of the topical translational research and clinically relevant topics in greater detail. We address recent updates in the genetics and epigenetics of MPN, the mechanisms of transformation by mutant calreticulin, advances in the biology and therapy of systemic mastocytosis, clinical updates on JAK2 inhibitors and other therapeutic approaches for patients with MPNs, cardiovascular toxicity related to tyrosine kinase inhibitors and the concept of treatment-free remission for patients with CML. | ||
| 650 | 4 | |a CALR | |
| 650 | 4 | |a Cardiotoxicity | |
| 650 | 4 | |a CML | |
| 650 | 4 | |a JAK2 inhibitors | |
| 650 | 4 | |a Mastocytosis | |
| 650 | 4 | |a MPN | |
| 650 | 4 | |a TFR | |
| 700 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 700 | 1 | |a Saußele, Susanne |d 1968- |e VerfasserIn |0 (DE-588)115839860 |0 (DE-627)69162786X |0 (DE-576)29010694X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia research |d Amsterdam [u.a.] : Elsevier Science, 1977 |g 67(2018), Seite 67-74 |h Online-Ressource |w (DE-627)320467031 |w (DE-600)2008028-1 |w (DE-576)095956301 |x 1873-5835 |7 nnas |a Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms |
| 773 | 1 | 8 | |g volume:67 |g year:2018 |g pages:67-74 |g extent:8 |a Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.leukres.2018.02.008 |x Verlag |x Resolving-System |z Pay-per-use |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0145212618300432 |x Verlag |z Pay-per-use |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190527 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 115839860 |a Saußele, Susanne |m 115839860:Saußele, Susanne |d 60000 |d 61200 |e 60000PS115839860 |e 61200PS115839860 |k 0/60000/ |k 1/60000/61200/ |p 10 | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |e 60000PH1037003489 |k 0/60000/ |p 8 | ||
| 999 | |a KXP-PPN1666322628 |e 3479747477 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"display":"Mughal, Tariq I.","family":"Mughal","role":"aut","given":"Tariq I."},{"role":"aut","given":"Rüdiger","display":"Hehlmann, Rüdiger","family":"Hehlmann"},{"display":"Saußele, Susanne","family":"Saußele","role":"aut","given":"Susanne"}],"name":{"displayForm":["Tariq I. Mughal, Jason Gotlib, Ruben Mesa, Steffen Koschmieder, H. Jean Khoury, Jorge E. Cortes, Tiziano Barbui, Rüdiger Hehlmann, Michael Mauro, Susanne Saussele, Jerald P. Radich, Richard A. Van Etten, Giuseppe Saglio, Srdnan Verstovek, Robert Peter Gale, Omar Abdel-Wahab"]},"physDesc":[{"extent":"8 S."}],"recId":"1666322628","relHost":[{"part":{"extent":"8","text":"67(2018), Seite 67-74","volume":"67","pages":"67-74","year":"2018"},"language":["eng"],"id":{"eki":["320467031"],"issn":["1873-5835"],"zdb":["2008028-1"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320467031","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasmsLeukemia research","origin":[{"publisher":"Elsevier Science","dateIssuedKey":"1977","dateIssuedDisp":"1977-","publisherPlace":"Amsterdam [u.a.]"}],"pubHistory":["1.1977 -"],"note":["Gesehen am 16.01.20","Ungezählte Beil.: Supplement"],"title":[{"title":"Leukemia research","subtitle":"clinical and laboratory studies","title_sort":"Leukemia research"}]}],"id":{"eki":["1666322628"],"doi":["10.1016/j.leukres.2018.02.008"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"14 February 2018"}],"note":["Gesehen am 27.05.2019"],"title":[{"title":"Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms","title_sort":"Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a MUGHALTARIRECENTADVA1420 | ||